CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project seeks to reform the current Intellectual Property Rights system for pharmaceuticals to improve access to essential medicines. It proposes a two-tiered patent system that allows for more affordable drug pricing while encouraging innovation in the pharmaceutical sector.
We seek to develop a plan for amending the current Intellectual Property Rights (IPR) regime for rewarding pharmaceutical innovations.
The existing IPR regime is highly problematic.
This has become obvious in the wake of a series of public health emergencies, most notably the AIDS crisis, which pits the vital needs of poor patients against the need of pharmaceutical companies to recoup their investments.
Amending the current system represents one of the major 21st century challenges, namely deli…
UNIVERSITY OF CENTRAL LANCASHIRE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Australia, Melbourne
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
France, Paris
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
